Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ) is established in Hong Kong Baptist University is invented by Prof. Aiping Lu (M.D., Ph.D.), the Chair Professor of Integrated Western Medicine and Traditional Chinese from School of Chinese Medicine in Hong Kong Baptist University. TMBJ was started on September 1st, 2012. Director of TMBJ is Prof. Aiping Lu. The work of the TMBJ is to improve quality of life at bone & joint aspects for the people in Hong Kong, mainland China and all over the world to demonstrate its leading role reputation of Hong Kong Baptist University in this field, which also aims to meet the necessity of ââ¬ËInnovative Researchââ¬â¢ by ââ¬ËStrategic Themes and Actions in Vision 2020 in Hong Kong Baptist Universityââ¬â¢. The objective of the TMBJ is to bid multidisciplinary scientists from Faculty of Science and School of Chinese Medicine effectively translate basic scientific findings information that welfares patients with bone and joint diseases, which is often described as an effort to carry scientific information ââ¬Ëfrom bench to bedââ¬â¢. To achieve the objective, the TMBJ is to function as a unit to integrate academic resource and industrial network to facilitate development of innovative bioinformatics approach to drug discovery, novel biological reagents, exclusive therapeutic agents, new biomaterials and advanced bio-imaging modalities for diagnosis, prevention and treatment toward Phase-I clinical trials and commercialization in bone & joint diseases. Research Focus The current research focus of the TMBJ covers drug discovery (drug design, drug synthesis and drug target), pharmaceutics (drug analysis and drug delivery), pre-clinical evaluation and clinical trial for bone and joint diseases. ââ¬Â¢ Drug Target ââ¬Â¢ Drug Design ââ¬Â¢ Drug Synthesis ââ¬Â¢ Drug Delivery ââ¬Â¢ Drug Analysis ââ¬Â¢ Pre-clinical Evaluation ââ¬Â¢ Clinical Trial Collaborative Platform Institute for Advancing Translational Medicine in Bone & Joint Disease have many collaboration platforms such as, ââ¬Â¢ Aptamer-based Translational Research Platform ââ¬Â¢ Drug Discovery Platform ââ¬Â¢ Bioinformatics & Drug Design Platform ââ¬Â¢ Pre-clinical Platform ââ¬Â¢ Clinical Trial & Biobank Platform ââ¬Â¢ Industrialization Platform
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi